CompoAtlas

oemine LAX

Food supplement declared in France, declaration No 2022-11-596, decision dated 12 November 2022

oemine LAX (oemine) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
oemine
Food business operator placing the product on the market
PHYTOBIOLAB
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
6 gélules par jour
Directions for use
Boire abondamment après la prise des gélules.
Not recommended for (according to the manufacturer)
Insuffisance rénale
Objectives stated by the manufacturer (these are not authorised claims)
Digestion

Declaration 189516, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Plantago ovata Forssk.TégumentPoudre (de plantes séchées ou broyées)1,998 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Chlorure de magnésiumMagnésium250 mg300 mg
Bicarbonate de sodiumSodiumpas de limite (données insuffisantes)aucune dose fixée

Additives

E1204

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

déconseillé en cas d’insuffisance rénale

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : oemine

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line